synbiointel.com — Synthetic Biology News https://synbiointel.com News, funding, and analysis for the synbio and synbio industry. en-us 60 <![CDATA[Precision BioSciences Misses Q1 Earnings Amid Gene Editing Volatility]]> https://synbiointel.com/news/precision-biosciences-q1-earnings-miss-gene-editing-volatility https://synbiointel.com/news/precision-biosciences-q1-earnings-miss-gene-editing-volatility Thu, 21 May 2026 09:10:32 GMT market <![CDATA[In Vivo Gene Editing Market Hits $37.75B by 2032]]> https://synbiointel.com/news/in-vivo-gene-editing-market-37-billion-forecast https://synbiointel.com/news/in-vivo-gene-editing-market-37-billion-forecast Wed, 20 May 2026 06:58:59 GMT market <![CDATA[Pictet Boosts Twist Bioscience Stake as DNA Synthesis Market Heats Up]]> https://synbiointel.com/news/pictet-increases-twist-bioscience-holdings https://synbiointel.com/news/pictet-increases-twist-bioscience-holdings Sun, 03 May 2026 09:46:39 GMT market <![CDATA[Mammoth Biosciences Eyes IPO After $150M Series D Close]]> https://synbiointel.com/news/mammoth-biosciences-ipo-series-d-150m https://synbiointel.com/news/mammoth-biosciences-ipo-series-d-150m Thu, 30 Apr 2026 13:20:43 GMT market <![CDATA[CRISPR Therapeutics Hits $2B Market Cap on CTX001 Data]]> https://synbiointel.com/news/crispr-therapeutics-2b-market-cap-ctx001 https://synbiointel.com/news/crispr-therapeutics-2b-market-cap-ctx001 Fri, 24 Apr 2026 20:45:33 GMT market <![CDATA[Caribou Biosciences Q4 2025 Loss Narrows, Shares Rise 2.3%]]> https://synbiointel.com/news/caribou-biosciences-q4-2025-earnings-beat https://synbiointel.com/news/caribou-biosciences-q4-2025-earnings-beat Wed, 22 Apr 2026 12:22:07 GMT market <![CDATA[Sumitomo Mitsui Dumps 217K Twist Bio Shares Worth $11M]]> https://synbiointel.com/news/sumitomo-mitsui-sells-twist-bioscience-shares https://synbiointel.com/news/sumitomo-mitsui-sells-twist-bioscience-shares Wed, 15 Apr 2026 09:52:54 GMT market <![CDATA[Evercore Raises Editas Price Target to $15 on CRISPR Pipeline]]> https://synbiointel.com/news/evercore-raises-editas-price-target-15-crispr-pipeline https://synbiointel.com/news/evercore-raises-editas-price-target-15-crispr-pipeline Tue, 14 Apr 2026 07:54:57 GMT market <![CDATA[Goldman Raises Generate Biomedicines Target to $26]]> https://synbiointel.com/news/goldman-raises-generate-biomedicines-target-26 https://synbiointel.com/news/goldman-raises-generate-biomedicines-target-26 Sat, 11 Apr 2026 02:36:11 GMT market <![CDATA[Editas Medicine Stock Drops Amid Clinical Trial Setbacks]]> https://synbiointel.com/news/editas-medicine-stock-drops-clinical-trial-setbacks https://synbiointel.com/news/editas-medicine-stock-drops-clinical-trial-setbacks Sun, 29 Mar 2026 03:54:02 GMT market <![CDATA[Absci Reports Q4 2025 Results: AI Drug Discovery Under Scrutiny]]> https://synbiointel.com/news/absci-q4-2025-earnings-ai-drug-discovery https://synbiointel.com/news/absci-q4-2025-earnings-ai-drug-discovery Mon, 23 Mar 2026 12:48:18 GMT market <![CDATA[Absci Trades at $2.86 Ahead of Critical Q4 Earnings]]> https://synbiointel.com/news/absci-trades-286-q4-earnings-march-24 https://synbiointel.com/news/absci-trades-286-q4-earnings-march-24 Thu, 19 Mar 2026 14:03:17 GMT market